QQ客服 官方微博 反馈留言

	OXALIPLATIN+5-FLUOROURACIL/LEUCOVORIN (FOLFOX4) IN ADVANCED HCC: UPDATED EFFICACY RESULTS OF THE EACH TRIAL (CPCI-S收录)
	Qin, S.[1]; Thongprasert, S.[2]; Lim, H. Y.[3]; Liang, L.[4]; Zhang, Y.[5]; Rau, K.[6]; Yang, T.[7]; Seetalakom, K.[8]; Kim, J. H.[9]; Zhou, Y.[10]
会议名称	ANNALS OF ONCOLOGY
URL标识	查看原文
内容类型	会议论文
URI标识	http://www.corc.org.cn/handle/1471x/2064249
专题	华南理工大学
作者单位	1.[1]Nanjing Bayi Hosp, Dept Med Oncol, PLA Canc Ctr, Nanjing, Peoples R China 2.[2]Chiang Mai Univ, Div Med Oncol, Chiang Mai 50000, Thailand 3.[3]Samsung Med Ctr, Div Hematol Oncol, Dept Med, Seoul, South Korea 4.[4]Sun Yat Sen Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China 5.[5]Sun Yat Sen Univ, Dept Hepatobiliary Tumor, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China 6.[6]Kaohsiung Chang Gung Mem Hosp, Div Hematol Oncol, Kaohsiung, Taiwan 7.[7]Chang Gung Mem Hosp, LinKou Med Ctr, Div Hematol Oncol, Tao Yuan, Taiwan 8.[8]Phramongkutklao Coll Med, Dept Med Oncol, Bangkok, Thailand 9.[9]Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seoul, South Korea 10.[10]Sanofi Aventis, Sanofi Aventis Asia Pacific Randd, Shanghai, Peoples R China
推荐引用方式 GB/T 7714	Qin, S.[1],Thongprasert, S.[2],Lim, H. Y.[3],等. OXALIPLATIN+5-FLUOROURACIL/LEUCOVORIN (FOLFOX4) IN ADVANCED HCC: UPDATED EFFICACY RESULTS OF THE EACH TRIAL (CPCI-S收录)[C]. 见:ANNALS OF ONCOLOGY.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。